Healthpeak Properties, Inc. (NYSE:DOC) Shares Bought by DnB Asset Management AS

DnB Asset Management AS raised its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 145,884 shares of the real estate investment trust’s stock after buying an additional 4,298 shares during the quarter. DnB Asset Management AS’s holdings in Healthpeak Properties were worth $2,957,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the business. Harvest Fund Management Co. Ltd purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $30,000. Groupama Asset Managment purchased a new stake in shares of Healthpeak Properties in the third quarter valued at approximately $37,000. Continuum Advisory LLC purchased a new position in Healthpeak Properties during the third quarter worth approximately $44,000. AdvisorNet Financial Inc lifted its position in Healthpeak Properties by 34.5% during the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after buying an additional 563 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new position in Healthpeak Properties during the fourth quarter worth approximately $45,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on DOC shares. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Wedbush reduced their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Mizuho dropped their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. Finally, Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Price Performance

DOC opened at $20.23 on Tuesday. The firm has a market cap of $14.15 billion, a price-to-earnings ratio of 57.79, a PEG ratio of 2.17 and a beta of 1.14. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock’s 50-day moving average price is $20.22 and its 200 day moving average price is $21.08. Healthpeak Properties, Inc. has a 12-month low of $17.80 and a 12-month high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were given a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a dividend yield of 6.03%. The ex-dividend date was Friday, February 14th. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.